"Covert toxocariasis" in a child treated with low-dose diethylcarbamazine.
A girl aged 2.5 years with "covert toxocariasis" was treated with low-dose diethylcarbamazine because of supposed noticeable disseminated Toxocara canis infection without ocular or visceral manifestations. There was marked blood and bone marrow eosinophilia, significant increased Toxocara canis antibody (ELISA) and immunoglobulins E, G and M, leucocytosis and an increased sedimentation rate. She had no geophagia, but often sucked small stones, probably contaminated with faeces from puppies. Symptoms were fever, inactivity, weakness, tiredness and loss of appetite. She was followed clinically and with blood samples throughout a period of three years and four months.
Rasmussen
L N
LN
Department of Paediatrics, Central Hospital, Herning, Denmark.
Dirdal
M
M
Birkebaek
N H
NH
D000818:Animals; D002675:Child, Preschool; D004049:Diethylcarbamazine / Q000008:administration & dosage*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007816:Larva Migrans, Visceral / Q000097:blood / Q000188:drug therapy*; D017166:Toxocara canis
D004049:Diethylcarbamazine